Navigation Links
Generex Provides Clarification for Special Meeting Voting
Date:10/14/2010

sults to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Such risks and uncertainties include the risks that: Generex will not obtain the stockholder approval of the reverse stock split; and the reverse stock split, if implemented, will fail to have the desired effect of sufficiently raising the common stock price to meet The NASDAQ Capital Market's $1.00 minimum bid price requirement for continued listing of Generex's stock. Known risks and uncertainties also include those identified from time to time in the reports filed by Generex with the Securities and Exchange Commission, which should be considered together with any forward-looking statement. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements. Generex undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Generex cannot be sure when or if it will be permitted by regulatory agencies to undertake additional clinical trials or to commence any particular phase of clinical trials. Because of this, statements regarding the expected timing of clinical trials or ultimate regulatory approval cannot be regarded as actual predictions of when Generex will obtain regulatory approval for any "phase" of clinical trials or when it will obtain ultimate regulatory approval by a particular regulatory agency. Generex claims the protection of the safe harbor for forward-looking statements that is contained in the Private Securities Litigation Reform Act.


'/>"/>
SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies
2. Generex Biotechnology Provides a Corporate Update to Address Managements Strategic Initiatives for Growth
3. Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System
4. Generex Presents Abstract at EASD Annual Meeting
5. Generex Announces Sales Agreement with Elias Shaker & Company
6. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
7. Generex Announces Presentations of Novel Vaccine Strategies
8. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
9. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
10. FDAs Just Approved Monthly Drug Treatment, Vivitrol Could Be Game Changer, Says Countrys Largest Drug Treatment Recovery President, CRCs Jerry Rhodes; Provides Addicts One Decision A Month Instead of 30
11. MuGard Provides Significant Improvement or Stabilization of Oral Mucositis in Over 75% of Patients in European Clinical Experience
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 2015  Cochlear Corporation Vice President of U.S. ... to join Valencia Technologies ( www.valenciatechnologies.com ) and ... , who is the CEO of Valencia.  Schloffman ... will be responsible for generating enthusiasm and support ... coin-sized neuromodulation device in the treatment of ...
(Date:3/30/2015)... 30, 2015   MultiVir Inc. ("MultiVir"), a ... product candidates for the treatment of multiple oncological indications, ... statement on Form S-1 with the U.S. Securities and ... offering of shares of its common stock. The number ... for the proposed offering have not yet been determined. ...
(Date:3/30/2015)... , March 30, 2015   GlassesUSA , the online ... of $12.5 million in new financing led by Viola ... funding will further GlassesUSA,s aggressive business growth and accelerate their ... of online eyewear, both B2C and B2B. GlassesUSA ... COO Eldad Rothman , and CTO Roy Yamner ...
Breaking Medicine Technology:Cochlear VP of U.S. Sales Jerry Schloffman Accepts Chief of Market Development Position at Valencia Technologies 2MultiVir Files Registration Statement for Proposed Initial Public Offering 2GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3
... Systems, Inc. (Nasdaq: DCTH ) today announced ... its 505(b)(2) New Drug Application (NDA) for its proprietary ... (FDA). The Company had previously submitted Module 4, consisting ... late April 2010. The Company is seeking an indication ...
... 2010 Regenicin, Inc. (OTC Bulletin Board: RGIN ... cell therapies to restore the health of damaged tissues and ... 11-13, 2011 in San Francisco. Randall McCoy, CEO of Regenicin, ... bringing new regenerative medicine products to market. ...
Cached Medicine Technology:Delcath Completes New Drug Application Submission to the FDA for the Chemosaturation Delivery System 2Delcath Completes New Drug Application Submission to the FDA for the Chemosaturation Delivery System 3Regenicin CEO to Present at OneMedForum Business Development and Finance Conference 2
(Date:3/31/2015)... 2015 There are times when doing ... But in their latest article , Clean Crawls ... make when doing their own crawl space repairs and ... mistake homeowners make is to add additional vents to ... crawl space. The article states that, “Unfortunately, studies have ...
(Date:3/31/2015)... March 31, 2015 Miraca Life Sciences, ... and expanded its breast pathology offering , to ... , Miraca Life Sciences’ breast pathology services feature:, ... Consensus-based approach to terminology and diagnostic criteria ... Heredity breast cancer panels , Molecular ...
(Date:3/31/2015)... March 31, 2015 First Choice ... emergency rooms in the United States, announced that it ... , “I am pleased to announce that we are ... in Haslet,” said Dr. James M. Muzzarelli, Executive Medical ... Choice Emergency Room is revolutionizing the delivery of emergency ...
(Date:3/31/2015)... March 31, 2015 The Buffalo ... peers across the country for distinguished service to its ... New York State Athletic Trainers’ Association (NYSATA) is proud ... these NYS athletic trainers - especially during March as ... Ed Block Courage Award for NFL Athletic Training ...
(Date:3/30/2015)... Minneapolis, MN (PRWEB) March 31, 2015 ... established to aid patients and family members who may ... Ondansetron, during pregnancy for morning sickness. The site was ... the conviction of GlaxoSmithKline in C.A. No. 11-10398-RWZ, filed ... The Toronto Star reports that this case ...
Breaking Medicine News(10 mins):Health News:Top 7 Crawl Space Mistakes Made by DIY Homeowners are Listed in New Article from Clean Crawls 2Health News:Top 7 Crawl Space Mistakes Made by DIY Homeowners are Listed in New Article from Clean Crawls 3Health News:Miraca Life Sciences Formalizes and Expands Breast Pathology Business 2Health News:Miraca Life Sciences Formalizes and Expands Breast Pathology Business 3Health News:First Choice Emergency Room to Open New Facility in Haslet, Texas 2Health News:NYS Athletic Trainers' Association Congratulates Buffalo Bills Athletic Training Staff for National Award 2Health News:NYS Athletic Trainers' Association Congratulates Buffalo Bills Athletic Training Staff for National Award 3Health News:Robert Gardner Law Announces Resource Site for Patients Prescribed Zofran During Pregnancy 2
... BIRMINGHAM, Ala., March 24 BioHorizons announces today ... Thursday, April 30, to Saturday, May 2, at ... on recent advances in digital dentistry, treatment planning, ... restorations.Scientific sessions will bring together the outstanding and ...
... March 24 Perrigo Company (Nasdaq: PRGO ... approval from the U.S. Food and Drug Administration to ... has been determined to be therapeutically equivalent (AB) to ... for the topical treatment of acne. Klaron(R) Lotion had ...
... stress the importance of genetic testing and diagnosis , , ... heart disorder called Danon disease progresses rapidly and is ... study. , The recently recognized disease is a type ... mutations in the lysosome-associated membrane protein gene (LAMP2). Until ...
... included doctor training, patient education and feedback, , , TUESDAY, ... be a better approach to helping people battle chronic ... including more than 400 U.S. veterans, researchers found that ... that included education for patients in pain and their ...
... Tissue Culture Cells ,Infection with human ... transcriptase (hTERT) gene in both normal human cells ... has been suspected of causing or promoting cancer, ... has been unclear. Several other cancer-related viruses stimulate ...
... University of Maryland,s Maryland Performance Excellence ... Mikulski and Benjamin Cardin, today announce the winners ... role-model organizations that successfully implement systematic processes for ... are evaluated rigorously by an independent board of ...
Cached Medicine News:Health News:BioHorizons Announces Its 2009 Global Symposium: Bringing Together Top Thought Leaders in the Dental Implant Industry to Provide Insight on Integrating Technology into the Continuum of Care 2Health News:Perrigo Announces FDA Approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion) 2Health News:Danon Disease Can Be Quickly Fatal, Study Finds 2Health News:Collaborative Care Helps Ease Chronic Pain 2Health News:Collaborative Care Helps Ease Chronic Pain 3Health News:Also in the March 24 JNCI 2Health News:Also in the March 24 JNCI 3Health News:Also in the March 24 JNCI 4Health News:Also in the March 24 JNCI 5Health News:Also in the March 24 JNCI 6Health News:Maryland Performance Excellence Awards Program Announces Winners of Maryland Quality Awards 2Health News:Maryland Performance Excellence Awards Program Announces Winners of Maryland Quality Awards 3Health News:Maryland Performance Excellence Awards Program Announces Winners of Maryland Quality Awards 4
Supplied sterile in peel-open packages. Intended for one-time use....
... Used for catheter positioning and exchange in ... the wire guide coils allows utilization of ... smooth transition to a very flexible tip. ... is the most rigid coiled wire guide ...
... catheter positioning and exchange ... inner diameter of wire ... of an extra heavy ... tip flexibility. Supplied sterile ...
Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: